Breaking news

Meta Loses Privacy Battle in Landmark Health Data Lawsuit

A California jury has dealt a significant setback to Meta in a high-profile privacy lawsuit alleging the collection and misuse of sensitive health data from the period-tracking app Flo. The verdict, rendered in the U.S. District Court for the Northern District of California, found that Meta breached the California Invasion of Privacy Act by failing to protect users’ confidential reproductive health information.

Big Tech Under the Microscope

The lawsuit, initiated in 2021 as a class-action case, brought together several major technology firms. Alongside Meta, companies such as Alphabet (Google’s parent company) and various data analytics firms were implicated. Flo Health, which had reassured its users that their sensitive data would remain private, saw its assurances undermined when its data was transmitted via software-development kits to these tech giants.

Legal Strategies and Corporate Response

While Google and one analytics firm chose to settle the claims before trial, Flo Health reached an agreement just before the conclusion of proceedings. Meta, however, elected to fight the allegations in court. Despite its robust defense, the jury verdict stands, a decision the company now plans to challenge on appeal. A Meta spokesperson dismissed the claims, asserting, “The plaintiffs’ claims against Meta are simply false,” and reaffirming the company’s commitment to user privacy by prohibiting the transmission of health or other sensitive information by developers.

Setting a Precedent for Digital Data Protection

The outcome of this case highlights the increasing pressure on major technology firms to handle user data responsibly. Lead trial lawyers Michael Canty and Carol Villegas remarked that the verdict sends a strong message regarding digital health data protection and the accountability of large tech companies. This decision not only underscores the potential legal risks associated with the covert monetization of personal data but also signals a broader shift towards more stringent digital privacy standards within the technology sector.

As Meta prepares to appeal the decision, industry observers note that this ruling could herald a new era of legal scrutiny over data handling practices across the tech landscape.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

Aretilaw firm
The Future Forbes Realty Global Properties
eCredo
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter